The NCRI Gynaecological Group has three subgroups that develop research in areas of strategic need.

The Cervix/Vulva Workstream, chaired by Dr Emma Hudson, develops research into cancer of the cervix or vulva.

Members:

Emma Hudson, Velindre NHS Trust (subgroup chair)

Susana Banerjee, Royal Marsden NHS Foundation Trust

Tara Barwick, Imperial College Healthcare NHS Trust – St Mary’s Hospital

Emma Cattell, Medical Oncologist, Somerset NHS Foundation Trust

Emma de Winton, Consultant, Royal United Hospitals Bath NHS Foundation Trust

Asma Faruqi, Barts Health NHS Trust

Jenny Forrest, King’s College London (KCL)

Lynn Hirschowitz, Birmingham Women’s and Children’s NHS Foundation Trust

Susan Lalondrelle, Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust

Rosemary Lord, Clatterbridge Cancer Centre NHS Foundation Trust

Jackie Martin, Sheffield Teaching Hospitals NHS Foundation Trust

Jess Mason, Clinical Oncologist, Somerset NHS Foundation Trust

Pinias Mukonoweshuro, Pathologist, Royal United Hospitals Bath NHS Foundation Trust

Nick Reed, Beatson West of Scotland Cancer Centre

Vanitha Sivalingam, Academic Clinical Lecturer in Gynaecological Oncology, University of Manchester

Alexandra Taylor, Consultant in Clinical Oncology, Royal Marsden NHS Foundation Trust

John Tidy, Sheffield Teaching Hospitals NHS Foundation Trust

Jeremy Twigg, King’s College London (KCL)

The Endometrial Workstream, chaired Dr Emma Crosbie, develops research into cancer of the endometrium, the lining of the uterus.

Members:

Emma Crosbie, Professor of Gynaecological Oncology, University of Manchester (subgroup chair)

Kinta Beaver, University of Central Lancashire

Andrew Clamp, Christie NHS Foundation Trust

Emma de Winton, Consultant, Royal United Hospitals Bath NHS Foundation Trust

Yvette Drew, Medical Oncologist, Newcastle upon Tyne Hospitals NHS Foundation Trust

Gemma Eminowicz, Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer, University College London Hospitals NHS Foundation Trust (UCLH)

Maria Kyrgiou, Imperial College Healthcare NHS Trust – St Mary’s Hospital

Rosemary Lord, Clatterbridge Cancer Centre NHS Foundation Trust

Christos Mikropoulos, Specialist Registrar, Maidstone and Tunbridge Wells NHS Trust – Kent Oncology Centre

Esther Moss, Honorary Associate Professor, University Hospitals of Leicester NHS Trust

Pinias Mukonoweshuro, Pathologist, Royal United Hospitals Bath NHS Foundation Trust

Jaya Nautiyal, Research Associate, Imperial College London

Christine Parkinson, Locum Consultant In Medical Oncology, Addenbrooke’s Hospital NHS Foundation Trust

Melanie E B Powell, Consultant Clinical Oncologist, Barts Health NHS Trust

Azmat Sadozye, Consultant, Beatson West of Scotland Cancer Centre

Naveena Singh, Barts Health NHS Trust

Axel Walther, University of Bristol

Karen Whitmarsh, Clinical Oncologist, Clatterbridge Cancer Centre NHS Foundation Trust

Dennis Yiannakis, Consultant Oncologist, Lancashire Teaching Hospitals NHS Foundation Trust

The Ovarian Workstream, chaired by Dr Rebecca Bowen, develops research into cancer of the ovaries.

Members:

Rebecca Bowen, Consultant Medical Oncologist, Royal United Hospitals Bath NHS Foundation Trust (subgroup chair)

Susana Banerjee, Royal Marsden NHS Foundation Trust

Michael-John Devlin, Clinical Research Fellow, Barts and The London School of Medicine and Dentistry

Mona El-Bahrawy, Consultant Histopathologist, Imperial College London

Christina Fotopoulou, Consultant Gynaecological Oncologist, Imperial College Healthcare NHS Trust – St Mary’s Hospital

Sadaf Ghaem-Maghami, Reader in Gynaecological Oncology, Imperial College London

Rosalind Glasspool, Consultant, University of Glasgow

Rebecca Kristeleit, Guy’s and St Thomas’ NHS Foundation Trust

Jonathan Ledermann, Divisional Clinical Director, University College London Hospitals NHS Foundation Trust (UCLH)

Rosemary Lord, Clatterbridge Cancer Centre NHS Foundation Trust

Iain McNeish, Professor of Oncology, Imperial College London

Shibani Nicum, , Oxford University Hospitals NHS Foundation Trust

Rachel O’Donnell, NIHR ACL and Gynaecological Oncology Surgeon, Newcastle University

Sundha Sundar, University Hospitals Birmingham NHS Foundation Trust

Axel Walther, University of Bristol

Nafisa Wilkinson, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Sarah Williams, Medical Oncologist, King’s College London (KCL)